Bicycle Therapeutics plc (BCYC) Operating income 2017–2025
Bicycle Therapeutics plc (BCYC) annual operating income history from SEC filings — each fiscal year as reported.
-$247.1MFY2025 · since FY2017: -$16.2M → -$247.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$247.1M | -17.7% |
| FY2024 | -$209.9M | -10.5% |
| FY2023 | -$189.9M | -62.8% |
| FY2022 | -$116.7M | -77.8% |
| FY2021 | -$65.6M | -26.3% |
| FY2020 | -$52.0M | -97.6% |
| FY2019 | -$26.3M | -20.9% |
| FY2018 | -$21.7M | -34.1% |
| FY2017 | -$16.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More BCYC financial trends
BCYC RevenueBCYC Net incomeBCYC Net marginBCYC Gross profitBCYC Gross marginBCYC Operating marginBCYC Operating cash flowBCYC Free cash flowBCYC Capital expendituresBCYC Return on equityBCYC Stock buybacksBCYC Dividends paidBCYC Total assetsBCYC Total liabilitiesBCYC Shareholders’ equityBCYC overview →